Serum and salivary cortisol in the diagnosis of adrenal insufficiency and as a predictor of the outcome in patients with severe sepsis;Avaliação do cortisol sérico e salivar no diagnóstico da insuficiência adrenal e como parâmetro preditor da evolução de pacientes com sepse grave

Arquivos Brasileiros de Endocrinologia e Metabologia

Volumn 55, Issue 7, 2011, Pages 455-459

  vaz de Mello, Rômulo Carvalho ^a   Sad, Eduardo F ^b   Andrade, Bertha Coelho ^a   Neves, Suzane Pretti Figueiredo ^a   Santos, Silvana Maria Elói ^a   Sarquis, Marta Maria S ^a,b   Marik, Paul E ^c   Dias, Eduardo Pimentel ^b  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^b HOSPITAL FELÍCIO ROCHO   (Brazil)

^c THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

Albumin; Circi; Postoperative patients; Salivary cortisol; Serum total cortisol; Severe sepsis

Indexed keywords

EID: 82955177004     PISSN: 00042730     EISSN: 16779487     Source Type: Journal    
DOI: 10.1590/s0004-27302011000700004     Document Type: Article

References (20)

1. Annane D, Maxime V, Ibraim F, Alvarez JC, Abe E, Boudou P. Diagnosis of adrenal insufficiency in severe sepsis and septic shock. Am J Repir Crit Care Med. 2006;174(12):1319-26.
2. Marik PE, Pastores SM, Annane D, Meduri GU, Sprung CL, Arlt W,et al. Recommendations for the diagnosis and management of corticosteroid insufficiency in critically ill adult patients: consensus statements from an international task force by the American College of Critical Care Medicine. Crit Care Med. 2008;36(6):1937-49.
3. Marik PE. Critical illness-related corticosteroid insufficiency. Chest. 2009;135:181-93.
4. Rivers EP, Gaspari M, Saad GA, Mlynarek M, Fath J, Horst HM, et al. Adrenal insufficiency in high-risk surgical ICU patients. Chest. 2001;19(3):889-96.
5. Marik PE, Zaloga GP. Adrenal insufficiency in the critically Ill: A new look at an old problem. Chest. 2002;122:1784-96.
6. Annane D, Sebille V, Charpentier C, Bollaert PE, François B, Kora-ch JM, et al. Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. JAMA. 2002;288:862-71.
7. Marik PE, Gayowski T, Starzl TE. The hepatoadrenal syndrome: a common yet unrecognized clinical condition. Crit Care Med. 2005;33:1254-59.
8. Annane D, Maxime V, Ibrahim F, Alvarez JC, Abe E, Boudou P, et al. Diagnosis of adrenal insufficiency in severe sepsis and septic shock. Am J Respir Crit Care Med. 2006;174(12):1319-26.
9. Oppert M, Schindler R, Husung C, Offermann K, Gräf KJ, Boenis-ch O, et al. Low-dose hydrocortisone improves shock reversal and reduces cytokine levels in early hyperdynamic septic shock. Crit Care Med. 2005;33(11):2457-64.
10. Bollaert PE, Charpentier C, Levy B, Debouverie M, Audibert G, Larcan A. Reversal of late septic shock with supraphysiologic doses of hydrocortisone. Crit Care Med. 1998(4);26:645-50.
11. Hamrahian AH, Oseni TS, Arafah BM. Measurement of serum free cortisol in critically ill patients. N Eng J Med. 2004;350:1629-38.
12. Ho JT, Al-Musalhi H, Chapman MJ, Quach T, Thomas PD, Bagley CJ, et al. Septic shock a sepsis: a comparison of total and free plasma cortisol levels. J Clin End Metabol. 2006;91:105-14.
13. Arafah BM, Nishiyama FJ, Tlaygeh H, Hejal R. measurement of salivary cortisol concentration in the assessment of adrenal function in critically ill subjects: a surrogate marker of the circulating free cortisol. J Clin Endocrinol Metab. 2007;92(3):2965-71.
14. Dimopoulou I, Alevizopoulou P, Dafni U, Orfanos S, Livaditi O, Tzanela M, et al. Pituitary adrenal response to human corticotro- phin releasing hormone in critically ill patients. Intensive Care Med. 2007;33(3):454-9.
15. Cohen J, Venkatesh B, Galligan J, Thomas P. Salivary cortisol concentration in the intensive care population: correlation with plasma cortisol values. Anaesth Inten Care. 2004;32:843-5.
16. Martinelli CE Jr, Sader SL, Oliveira EB, Daneluzzi JC, Moreira AC. Salivary cortisol for screening of Cushing's syndrome in children. Clin Endocrinol. 1999;51(1):67-71.
17. Castro M, Elias LLK, Elias PCL, Moreira AC. A dose-response study of salivary cortisol after dexamethasone suppression test in Cushing's disease and its potential use in the differential diagno- sis of Cushing syndrome. Clin Endocrinol. 2003;59(6):800-5.
18. Castro M, Moreira AC. Análise crítica do cortisol salivar na avaliação do eixo hipotálamo-hipófise-adrenal. Arq Bras Endocrinol Metab. 2003;47(1):358-67.
19. Levy MM, Fink MP, Marshall JC, Abraham E, Angus D, Cook D, et al. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit Care Med. 2003;31(4):1250-6.
20. Gozansky WS, Lynn JS, Laudenslager ML, Kohrt WM. Salivary cortisol determined by enzyme immunoassay is preferable to serum total cortisol for assessment of dynamic hypothalamic-pituitary-adrenal axis activity. Clin Endocrinol. 2005;63(3):336-41.